Add to ORKGated with overall survival in our cohort. Conclusions: FGFR3 expression in invasive breast cancer was not found to be sig-nificantly associated with specific clinicopathological/mo-lecular parameters, but might be used as a candidate marker for a poor prognosis. Copyright © 2010 S. Karger AG, Base
BACKGROUND: Breast cancer detected by screening has an unexplained prognostic advantage beyond stage...
Background: Breast cancer is one of the most common malignancies in women. Genome-wide association s...
Purpose: Breast cancer is a highly heterogeneous malignancy, seriously threatening female health wor...
Purpose Identification of single-gene biomarkers that are prognostic of outcome can shed new insight...
Among new prognostic factors for breast cancer, the most promising one seems to be FGD3 (Facio-Genit...
BACKGROUND: Basic fibroblast growth factor (bFGF) is a potent angiogenic and mitogenic factor that h...
Fibroblast growth factor receptor (FGFR) gene amplification has been reported in different types of ...
Background. Esophageal squamous cell carcinoma was treated by operation and chemoradiotherapy. Howev...
Background. Clinical trials based on FGFR mutation or amplification as a druggable target of FGFR in...
Fibroblast growth factor receptor 3 (FGFR3) is expressed in squamous cell carcinoma of the head and ...
BACKGROUND: Triple negative breast cancer (TNBC) accounts for 16% of breast cancers and represents a...
Purpose: Breast cancer is a highly heterogeneous malignancy, seriously threatening female health wor...
Breast cancer is one of the most common malignancies in women. Genome-wide association studies have ...
Purpose: Fibroblast growth factor receptor 3 (FGFR3) mutations were recently found at a high frequen...
Purpose:Fibroblast growth factor 2 (FGF2; basic fibroblast growth factor, b-FGF) and its main recept...
BACKGROUND: Breast cancer detected by screening has an unexplained prognostic advantage beyond stage...
Background: Breast cancer is one of the most common malignancies in women. Genome-wide association s...
Purpose: Breast cancer is a highly heterogeneous malignancy, seriously threatening female health wor...
Purpose Identification of single-gene biomarkers that are prognostic of outcome can shed new insight...
Among new prognostic factors for breast cancer, the most promising one seems to be FGD3 (Facio-Genit...
BACKGROUND: Basic fibroblast growth factor (bFGF) is a potent angiogenic and mitogenic factor that h...
Fibroblast growth factor receptor (FGFR) gene amplification has been reported in different types of ...
Background. Esophageal squamous cell carcinoma was treated by operation and chemoradiotherapy. Howev...
Background. Clinical trials based on FGFR mutation or amplification as a druggable target of FGFR in...
Fibroblast growth factor receptor 3 (FGFR3) is expressed in squamous cell carcinoma of the head and ...
BACKGROUND: Triple negative breast cancer (TNBC) accounts for 16% of breast cancers and represents a...
Purpose: Breast cancer is a highly heterogeneous malignancy, seriously threatening female health wor...
Breast cancer is one of the most common malignancies in women. Genome-wide association studies have ...
Purpose: Fibroblast growth factor receptor 3 (FGFR3) mutations were recently found at a high frequen...
Purpose:Fibroblast growth factor 2 (FGF2; basic fibroblast growth factor, b-FGF) and its main recept...
BACKGROUND: Breast cancer detected by screening has an unexplained prognostic advantage beyond stage...
Background: Breast cancer is one of the most common malignancies in women. Genome-wide association s...
Purpose: Breast cancer is a highly heterogeneous malignancy, seriously threatening female health wor...